Azamian Bobak R.
- SEC CIK
- 0001827672
In the past year, 5 open-market sale filings worth $5.18M and no purchases.
Current role at each company
- TARS Tarsus Pharmaceuticals, Inc.President/CEO and Board Chairas of Sep 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $5.18M
- 5 filings
- Net
- −$5.18M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Azamian Bobak R. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 26, 2025 (view filing) | Sep 24 | 2 days | Azamian Bobak R.President/CEO and Board Chair | SSale | −6.00K | $55.37 | −$332.2K | −0.7%812.1K after | 10b5-1 |
| Dec 30, 2025 (view filing) | Dec 24 | 6 days | Azamian Bobak R.President/CEO and Board Chair | SSale | −6.00K | $82.51 | −$495.1K | −0.7%858.0K after | 2 lots10b5-1 |
| Mar 19, 2026 (view filing) | Mar 17-19 | 2 days | Azamian Bobak R.President/CEO and Board Chair | SSale | −34.6K | $68.34 | −$2.36M | −50.9%33.4K after | 3 lots |
| Jun 22, 2026 (view filing) | Jun 17 | 5 days | Azamian Bobak R.President/CEO and Board Chair | SSale | −10.0K | $61.55 | −$615.5K | −1.2%848.0K after | 2 lots10b5-1 |
| Sep 3, 2026 (view filing)4:30 PM ET | Sep 2 | 1 day | Azamian Bobak R.President/CEO and Board Chair | SSale | −10.0K | $80.06 | −$800.6K | −1.2%838.0K after | 10b5-1 |
| Sep 9, 2026 (view filing)4:14 PM ET | Sep 4 | 5 days | Azamian Bobak R.President/CEO and Board Chair | SSale | −10.0K | $90.56 | −$905.6K | −1.2%828.0K after | 2 lots10b5-1 |